Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery (TB-MET-NAC)

NCT07136987 is registered in ClinicalTrials.gov with Open Source Pharma Foundation as lead sponsor.

NCT NCT07136987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery (TB-MET-NAC)
Lead sponsor
Open Source Pharma Foundation
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
July 31, 2031
Enrollment
1,104 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis